Pediatric Cardiology Market to Reach US$ 6.5 Billion by 2034, Fueled by Rising Prevalence of Congenital Heart Disorders (CHD) and Surgical Interventions |TMR

Procedurally, improvements such as minimally invasive catheter-based interventions have revolutionized remedy procedures. The seriousness of congenital heart defects (CHDs) in pediatric cardiology is evident in the extensive research and development efforts aimed at improving outcomes.

WILMINGTON, Del., July 24, 2024 /PRNewswire/ -- The global pediatric cardiology market is projected to total a valuation of nearly US$ 4.3 billion in 2024. During the forthcoming forecast period, the ecosystem is slated to rise at a CAGR of 3.9% to total US$ 6.5 billion. The global pediatric cardiology market is expected to grow considerably, driven by technological advancements, improved healthcare infrastructure, and supportive government policies.

The increase in the prevalence of congenital heart disorders (CHD) is driving the pediatric cardiology devices market. It is estimated that about one-third of babies born with CHD require some form of intervention early in life, with the majority needing open-heart surgery.

The global pediatric cardiology market is expected to grow considerably, driven by technological advancements, improved healthcare infrastructure, and supportive government policies. Innovations in minimally invasive procedures, catheter-based therapies, and heart transplant programs underscore the importance and complexity of treating congenital heart diseases in pediatrics.

Focusing on CHDs in pediatric cardiology not only addresses a critical need but also propels advancements in medical technologies and treatment protocols that benefit a wide range of patients. Funding for research and development in paediatric cardiology has also increased significantly, promoting innovation and the development of new diagnostic and treatment procedures. Nonprofit organisations play an important role in this environment by promoting awareness, sponsoring research, and assisting families impacted by paediatric cardiac diseases.

Request Your Sample Report Today:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86160

Organizations such as the American Heart Association and the British Heart Foundation perform substantial outreach and educational initiatives to educate the general public and healthcare practitioners on the importance of CHD screening and management. These organisations also promote policy reforms and improved funding for paediatric cardiology research.

Despite significant progress in medical diagnosis and intervention, challenges remain in the care of patients with CHD. These challenges affect not only patients but also cardiac surgeons, general cardiologists, and CHD specialists. Additionally, compared to high-income countries, there are far fewer comprehensive pediatric heart centers capable of performing infant and newborn heart surgeries in low- and middle-income countries, posing a significant challenge for the growth of the pediatric cardiology market over the forecast period.

Focusing on CHDs in pediatric cardiology not only addresses a critical need but also propels advancements in medical technologies and treatment protocols that benefit a wide range of patients. Funding for research and development in paediatric cardiology has also increased significantly, promoting innovation and the development of new diagnostic and treatment procedures. Non-profit organisations play an important role in this environment by promoting awareness, sponsoring research, and assisting families impacted by paediatric cardiac diseases.

Organizations such as the American Heart Association and the British Heart Foundation perform substantial outreach and educational initiatives to educate the general public and healthcare practitioners on the importance of CHD screening and management. These organisations also promote policy reforms and improved funding for paediatric cardiology research.

Despite significant progress in medical diagnosis and intervention, challenges remain in the care of patients with CHD. These challenges affect not only patients but also cardiac surgeons, general cardiologists, and CHD specialists. Additionally, compared to high-income countries, there are far fewer comprehensive pediatric heart centers capable of performing infant and newborn heart surgeries in low and middle-income countries, posing a significant challenge for the growth of the pediatric cardiology market over the forecast period.

Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86160

Key Takeaways from the Market Report

• As of 2023, the global pediatric cardiology market was valued at US$ 4.3 billion.
• From 2024 to 2034, the market is projected to expand 1.4x.
• By product, demand for pediatric cardiology catheters to experience elevated demand.
• Congenital heart disease (CHD) to be the primary application area for pediatric cardiology in the coming years.
• Pediatric cardiology procedures are expected to be conducted maximum across hospitals.

Pediatric Cardiology Market Drivers and Trends

• Rising prevalence of CHD is driving the pediatric cardiology devices market. It is estimated that about one-third of infants born with CHD require some form of intervention early in life, with the majority needing open-heart surgery.
• The market is expected to grow considerably, driven by technological advancements, improved healthcare infrastructure, and supportive government policies.
• Innovations in minimally invasive procedures, catheter-based therapies, and heart transplant programs underscore the importance and complexity of treating congenital heart diseases in pediatrics.
• Advancements in minimally invasive procedures, catheter-based therapies, and heart transplant programs highlight the significance and complexity of treating congenital heart diseases in the pediatric field.

Pediatric Cardiology Market Report Scope:

Regional Profile of the Pediatric Cardiology Landscape

• North America is a potential market for investing in pediatric cardiology treatment, with the United States being the pivot. The scope is heightened primarily because of an increasing prevalence of CHDs.
• It is estimated that at least 1%, or 40,000 of all infants born in the country are affected by CHD. About 1 in 4 babies with a heart defect have a critical heart defect. Infants with critical heart defects generally need surgery or other procedures in their first year of life.
• Given the complexity of multidisciplinary treatment and the rise in life expectancy of people living with CHD, patients in rural places may have different results than those in metropolitan areas. However, there is a lack of data on rural-urban inequalities in CHD-related mortality.

Competitive Landscape

From engaging in collaborative partnerships to launching new products, players in the global pediatric cardiology market hope to secure a substantial revenue share in forthcoming years. Characterized by the presence of various prominent players, the industry is significantly competitive.

Players such as Medtronic, and Edwards Lifesciences, are investing in research and development activities to launch innovative catheter technologies. Their objective is to meet the growing demands of the market, as the number of pediatric patients needing interventional cardiology procedures continues to rise.

Some of the prominent pediatric cardiology market players profiled in the report are as follows:

• Abbott Laboratories
• Medtronic
• Siemens Healthineers
• Edward Life Sciences
• Terumo Medical
• W.L. Gore & Associates
• Heart Medical
• Other Prominent Players

Key Developments

• In June 2024, Abbott Laboratories received the CE Mark in Europe for its AVIER^TM dual chamber (DR) leadless pacemaker system. This is the world's first leadless pacemaker that treats people with abnormal or slow rhythms. It utilizes a new method of delivering dual chamber therapy- one pacing the right ventricle and the other the right atrium.
• Medtronic received the FDA expanded approval for its Freezor^TM and Freezor^TM Xtra Cardiac Cryoablation Focal Catheters. These catheters are deployed to treat pediatric atrioventricular nodal reentrant tachycardia (AVNRT), a life-threatening abnormal heart rhythm.

Market Segmentation

Product Type

• Transcatheter Heart Valves
• Occlusion Devices
• Atherectomy Devices
• Catheters
• Stents
• Others

Application

• Congenital Heart Diseases
• Acquired Heart Diseases
• Arrhythmias
• Cardiomyopathies
• Others

End User

• Hospitals
• Speciality Centers
• Others

Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=86160&ltype=S

More Trending Reports by Transparency Market Research –

• Point-of-Care Glucose Testing Market - The global point-of-care glucose testing market is projected to flourish at a CAGR of 4.3% from 2022 to 2032. A valuation of US$ 5.8 billion is anticipated for the market in 2032. As of 2023, the market for point-of-care glucose testing is expected to close at US$4.0 billion.
• Dental Implant Motors Market - The global dental implant motors market is expected to grow at a CAGR of 3.5% during the forecast period from 2021 to 2031.
• Genotyping Assays Market is expected to grow at a CAGR of 22.5% from 2024 to 2034 and reach US$ 285.3 Bn by the end of 2034.
• Food Allergy Market is expected to grow at a CAGR of 5.9% from 2024 to 2034 and reach US$ 69.4 Bn by the end of 2034.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com   
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn | Twitter | Blog | YouTube

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg